---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029775"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:21:04.851692+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Glucotrack secures $4M convertible note from leading shareholder for CBGM clinical trial

## Summary
- $4M secured convertible note from John Ballantyne at 8% interest, due in 12 months or upon sale event.
- Note conversion requires stockholder approval; conversion at closing price or auto-convert if stock exceeds $5.
- Three warrants issued: 2.13M shares at $1.875, 1.52M at $2.625, 1.19M at $3.375; exercisable after 12 months for 10 years.
- Directors Shimon Rapp and Andrew Sycoff resigned July 29, no dispute.
- Proceeds to fund first-in-human clinical trial of implantable continuous blood glucose monitor.

## SEC filing metadata
- accession: 0001493152-24-029775
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315224029775/0001493152-24-029775-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315224029775/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029775
- JSON: https://secwatch.observer/filing/0001493152-24-029775.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029775.txt

## Key facts
- Executive change
  Shimon Rapp resigned as Director at Glucotrack, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315224029775/0001493152-24-029775-index.htm
- Executive change
  Andrew Sycoff resigned as Director at Glucotrack, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315224029775/0001493152-24-029775-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.